Signature Healthcare Of Port Charlotte Medicare and Medicaid Location: 4033 Beaver Lane, Port Charlotte, Florida 33952 Ratings: Phone: (941) 625-3200 |
Port Charlotte Rehabilitation Center Medicare and Medicaid Location: 25325 Rampart Blvd, Port Charlotte, Florida 33948 Ratings: Phone: (941) 629-7466 |
Harbour Health Center Medicare and Medicaid Location: 23013 Westchester Blvd, Port Charlotte, Florida 33980 Ratings: Phone: (941) 625-1220 |
Solaris Healthcare Charlotte Harbor Medicare and Medicaid Location: 4000 Kings Hwy, Port Charlotte, Florida 33980 Ratings: Phone: (941) 255-5855 |
Consulate Health Care Of Port Charlotte Medicare and Medicaid Location: 18480 Cochran Blvd, Port Charlotte, Florida 33948 Ratings: Phone: (941) 743-4700 |
Douglas Jacobson State Veterans Nursing Home Medicare and Medicaid Location: 21281 Grayton Terrace, Port Charlotte, Florida 33954 Ratings: Phone: (941) 613-0919 |
Village Place Health And Rehabilitation Center Medicare and Medicaid Location: 2370 Harbor Blvd, Port Charlotte, Florida 33952 Ratings: Phone: (941) 624-5966 |
News Archive
Childhood trauma is a potent risk factor for development of chronic fatigue syndrome (CFS), according to a study by researchers at Emory University School of Medicine and the Centers for Disease Control and Prevention (CDC).
Current methods of detecting lung cancer consist of imaging methods and invasive biopsies, which can be stressful and painful for patients.
The recent outbreak of a lethal combination of HIV and TB in southern Africa has prompted Britain to pledge an extra US$ 3.15 million to the World Health Organization's Stop TB partnership.
Sectra announces its multi-year agreement with Nashville General Hospital at Meharry. Sectra's suite of web-based, integrated RIS/PACS solutions for radiology, breast imaging and orthopaedics will enable the hospital to automate workflow, speed image distribution and report turnaround to improve its service level to referring physicians and increase referring volume.
Lung cancer patients given amrubicin (Calsed) as a second-line therapy had a significantly improved response rate and longer progression-free survival than patients treated with topotecan (Hycamtin), according to research presented at the 14th World Conference on Lung Cancer in Amsterdam, hosted by the International Association for the Study of Lung Cancer.
› Verified 7 days ago